New target, new drug, old paradigm

被引：19
|
作者：
Hidalgo, M [1 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 12期
关键词：
D O I：
10.1200/JCO.2004.03.918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2270 / 2272
页数：3
相关论文
共 50 条
  • [1] New Paradigm or Old Distance to Target?
    Weidema, Bo P.
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2012, 46 (02) : 570 - 570
  • [2] HEPARIN - OLD DRUG WITH A NEW PARADIGM
    JAQUES, LB
    SCIENCE, 1979, 206 (4418) : 528 - 533
  • [3] Chromatin - a new, old drug target?
    Davey, Gabriela E.
    Davey, Curt A.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (03) : 165 - 170
  • [4] New target, old drug for malaria
    Bradbury, J
    LANCET INFECTIOUS DISEASES, 2003, 3 (11): : 677 - 677
  • [5] Cellular target engagement: a new paradigm in drug discovery
    Babic, Ivan
    Kesari, Santosh
    Nurmemmedov, Elmar
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (14) : 1641 - 1644
  • [6] Mitotane Revisited: A New Target for an Old Drug
    Lalli, Enzo
    ENDOCRINOLOGY, 2015, 156 (11) : 3873 - 3875
  • [7] Turning a Drug Target into a Drug Candidate: A New Paradigm for Neurological Drug Discovery?
    Buckingham, Steven D.
    Mann, Harry-Jack
    Hearnden, Olivia K.
    Sattelle, David B.
    BIOESSAYS, 2020, 42 (09)
  • [8] Spironolactone and XPB: An Old Drug with a New Molecular Target
    Gabbard, Ryan D.
    Hoopes, Robert R.
    Kemp, Michael G.
    BIOMOLECULES, 2020, 10 (05)
  • [9] New paradigm of an old target: An update on structural biology and current progress in drug design towards plasmepsin II
    Dan, Nirnoy
    Bhakat, Soumendranath
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 95 : 324 - 348
  • [10] New paradigm for some, old paradigm for others
    Holburn, S
    MENTAL RETARDATION, 2000, 38 (06): : 530 - 531
12345